Amarin Corp Plc (AMRN)

[Jasbg]

xbl@ The news is out a lot more than most think !

https://seekingalpha.com/news/3643938-amarin-up-7-on-encouraging-vascepa-data-in-covidminus-19-and-cardiovascular-events

https://twitter.com/dlbhattmd?lang=da

https://thefly.com/landingPageNews.php?id=3212535&headline=AMRN-Amarins-Vascepa-showed-encouraging-results-in-Covid-patients-says-Piper

https://www.prnewswire.com/news-releases/canadian-pilot-study-suggests-prescription-icosapent-ethyl-vascepa-might-improve-symptoms-of-covid-19-and-reduce-inflammation-301191627.html

https://www.globenewswire.com/fr/news-release/2020/12/13/2144146/0/en/amarin-reports-encouraging-efficacy-and-safety-results-from-pilot-study-treating-covid-19-infected-outpatients-with-vascepa-icosapent-ethyl-in-late-breaker-presentation-at-national.html

https://www.biospace.com/article/releases/amarin-highlights-multiple-vascepa-icosapent-ethyl-related-scientific-findings-presented-at-national-lipid-association-nla-scientific-sessions-2020-including-first-covid-19-clinical-results/

LATE BREAKING PRESENTATION at NLA virtual Sessions next week: First Human Trial of a Loading Dose of Icosapent Ethyl in Patients with COVID-19: Primary Results of the VASCEPA COVID-19 CardioLink-9 Randomized Trial. Presenting author @DLBHATTMD https://t.co/JEyKHaRXhK pic.twitter.com/NGpBiNl2Ni

— National Lipid Association (@nationallipid) December 1, 2020

https://mashupmd.com/amarin-reports-encouraging-efficacy-and-safety-results-from-pilot-study-treating-covid-19-infected-outpatients-with-vascepa-icosapent-ethyl-in-late-breaker-presentation-at-national-lipid-assoc/

https://www.firstwordpharma.com/node/1782889?tsid=3

https://www.pm360online.com/amarin-reports-encouraging-efficacy-and-safety-results-from-pilot-study-treating-covid-19-infected-outpatients-with-vascepa-icosapent-ethyl-in-late-breaker-presentation-at-national-lipid-assoc-2/

https://www.stockwatch.com/News/Item?bid=Z-C:HLS-3004824&symbol=HLS®ion=C

https://www.lipid.org/nla/national-lipid-association-announces-late-breaking-abstract-presentations-nla-2020-virtual

Just links to a few of them :)

But JT interview on CNBC - and FOX News would still be fine - for sure. I guess Amarin will wait until more date is available.